BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BG Medicine Files for $80 Million IPO


8/6/2007 8:15:20 AM

WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine, Inc. today announced it has filed a registration statement on Form S-1 with the United States Securities and Exchange Commission (SEC) for a proposed Initial Public Offering (IPO) of its common stock. All of the shares to be offered will be sold by the company. The number of shares to be sold and the price range for the offering have not yet been determined. BG Medicine intends to apply for its common stock to list and trade on Euronext Amsterdam by NYSE Euronext under the symbol "BGMDX".

Cowen International Limited and Fortis will be acting as joint global coordinators and joint book-runners for the offering. Leerink Swann & Company will act as co-manager.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. In addition, the offering is subject to approval of the prospectus by the Netherlands Authority for the Financial Markets (AFM), the entity that supervises the operation of the financial markets in the Netherlands. The registration statement is available at www.sec.gov.

BG Medicine securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective and the AFM has approved the prospectus.

This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. A copy of the prospectus, when available, may be obtained from the prospectus department of Cowen International Limited, 1 Snowden Street, 11th floor, London EC2A 2DQ United Kingdom or Fortis Bank (Nederland) N.V., Rokin 55, 1012 KK, Amsterdam, The Netherlands.

About BG Medicine

BG Medicine is a life sciences company focused on the discovery, development and commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. BG Medicine discovers biomarkers and develops its diagnostic product candidates using its proprietary, versatile, and scalable technology platform which integrates and automates the precise measurement, analysis, characterization and interpretation of thousands of proteins, metabolites and nucleic acids collected from bodily fluids. BG Medicine is leveraging its technology platform in multiple biomarker initiatives and collaborations with TNO, Philips, major pharmaceutical companies, other healthcare organizations and the U.S. Food and Drug Administration.

Contact: Citigate First Financial Frank Jansen or Floor van Maaren, +31 (0)20 575 40 10

Source: BG Medicine, Inc.



Read at Reuters
Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES